{
  "docId": "019de073-a4f9-77e5-8cbf-a98a0ec20f41",
  "docSlug": "527bf315fca9a14279ec523dc4665564",
  "documentTitle": "Athira Pharma | Results Presentation Deck | 11 slides",
  "authorId": "athira-pharma",
  "authorName": "Athira Pharma",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 6,
  "pageCount": 11,
  "prevPage": 5,
  "nextPage": 7,
  "slideType": "other",
  "function": "present_framework",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide uses a process-flow style table to outline the clinical trial structure.",
  "elementsJson": null,
  "metadataConfidence": 0.9,
  "imagePath": null,
  "slideHref": "/slides/019de073-a4f9-77e5-8cbf-a98a0ec20f41/6",
  "deckHref": "/decks/019de073-a4f9-77e5-8cbf-a98a0ec20f41",
  "deckJsonHref": "/decks/019de073-a4f9-77e5-8cbf-a98a0ec20f41.json",
  "deckAnchorHref": "/decks/019de073-a4f9-77e5-8cbf-a98a0ec20f41#slide-6",
  "components": [
    {
      "bbox": {
        "h": 0.08,
        "w": 0.6,
        "x": 0.15,
        "y": 0.9
      },
      "kind": "source-note",
      "text": "AChEI, acetylcholinesterase inhibitor; ADAS-Cog11, Alzheimer's Disease Assessment Scale-Cognitive Subscale; ADCS-ADL23, Alzheimer's Disease Cooperative Study-Activities of Daily Living; ADCS-CGIC, Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change; CDR, clinical dementia rating; GST, global statistical test; MMSE, mini-mental state examination; NfL, neurofilament light chain; OLEX, open-label extension.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "49db2c1a-850f-4595-a335-f9941fea4927",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.65,
        "w": 0.95,
        "x": 0.03,
        "y": 0.2
      },
      "kind": "table",
      "text": "Population, Treatment Duration, and Results columns defining the study parameters.",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b559f69c-7b96-4ed9-a7e9-864881d9427b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.6,
        "x": 0.03,
        "y": 0.12
      },
      "kind": "title",
      "text": "LEARNINGS FROM ACT-AD INFORM STUDY DESIGN OPTIMIZATION",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7809718c-2cc6-4031-9bdf-4f42356c8361",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.5,
        "x": 0.03,
        "y": 0.05
      },
      "kind": "title",
      "text": "Fosgonimeton Phase 2/3 LIFT-AD Study Design",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4a164a84-47c1-4d3a-86a0-8ecc5f28216a",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 11,
      "from": 4,
      "beatId": "ec20a1da-004a-4f5b-ac24-cdc67eafb0cd",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Solution",
      "beatSlug": "problem-agitate-solution-solution-provide-relief",
      "evidence": "Fosgonimeton shows promise as a new potential therapy for Alzheimer's disease",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [
    {
      "to": 11,
      "from": 4,
      "name": "Jobs To Be Done",
      "slug": "53-jobs-to-be-done",
      "bestFor": "Product innovation, market entry, competitive positioning",
      "matchId": "8b9b785b-4f0f-46be-8af5-f2f0d1f429d0",
      "evidence": "Clear presentation of study results and next steps",
      "position": 1,
      "objective": "What are the key takeaways from the Phase 2/3 LIFT-AD study?",
      "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit",
      "confidence": 0.7,
      "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}